We hate to be the one to state the obvious (again), but how much more like a bad pandemic movie is this so-called “Ebola crisis” going to be allowed to get?
Yes. “Allowed.” The word was chosen carefully here. Why?
Let’s start back at in oh, let’s go with June, back when Ebola first began murdering people in Guinea, Liberia, and Sierra Leone. Somewhere between 300 and 400 people had died, and the news was still fit for little more than the ticker tape at the bottom of the screen on most 24/7 networks. Barely anyone was even paying attention. People shrugged it off with little fanfare and the apathetic attitude of, “Well, that’s just what happens in Africa sometimes…”
The death toll continued to rise. Ebola continued to openly spread. No travel restrictions between borders were put in place. No air travel bans were instituted. No nothing. Finally officials had to call it — this Ebola outbreak was the deadliest in known human history. So what did that change?
Not much. The World Health Organization (WHO) declared the situation was “totally out of control” and “one of the most challenging Ebola outbreaks ever.” So challenging in fact, that they rushed to action by…calling a meeting.
Meanwhile, more people died. The virus continued to spread. The healthcare system in these African nations was finally — not surprisingly — overwhelmed. No one in the mainstream press bothered to mention the fact that biowarfare researchers from Tulane University and the U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick had just so happened to have been over in the Ebola hot zone countries, propagating cultures of different types of Ebola viruses (and Marburg virus and Lassa virus and Dengue virus and West Nile virus and yellow fever virus and chikungunya virus) in labs in the years leading up to this outbreak.
Here’s one of the scholarly articles published from that research just this past July in the CDC’s journal Emerging Infectious Diseases.
In it, the researchers conclude, “PRNT is the laboratory standard for immunologic assays… In the ebolavirus PRNTs, we did not include the newest discovered ebolavirus, Bundibugyo virus, which cross-reacts with EBOV [Ebola virus] in immunoassays. Ebolavirus infections in Sierra Leone might be the result of Bundibugyo virus or an ebolavirus genetic variant and not EBOV.”
By the way, there are five types of Ebola virus and the newest strain is named Bundibugyo, or Ebobun for short. The U.S. government actually holds a patent on this strain — US 20120251502 A1, for “Human Ebola Virus Species and Compositions and Methods Thereof” related to the Bundibugyo version of the virus.
Jon Rappoport was one of the few alternative journalists who actually reported on this:
The research program, occurring in Sierra Leone, the Republic of Guinea, and Liberia—said to be the epicenter of the 2014 Ebola outbreak—has the announced purpose, among others, of detecting the future use of fever-viruses as bioweapons.
Is this purely defensive research? Or as we have seen in the past, is this research being covertly used to develop offensive bioweapons?
Written by Melissa Melton
Read more at TruthStream Media